FDA Approved: ASPARLAS — Original Application (Servier Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved ASPARLAS (calaspargase pegol) from Servier Pharmaceuticals as a treatment for acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparlas (calaspargase pegol)

Snippet

ORIG AP for ASPARLAS (CALASPARGASE PEGOL)